MAPLE GROVE, Minn.--(BUSINESS WIRE)--Entellus Medical today announced that it has entered into a licensing agreement with Acclarent, Inc. in order to resolve their patent lawsuit. The license agreement is royalty bearing to Acclarent. Additional financial details were not disclosed.
As part of the agreement, the companies will file a joint request for the termination of a patent infringement proceeding brought by Acclarent against Entellus on July 28, 2010 in the U.S. District Court for the Northern District of California.
“We are pleased to have reached a mutually beneficial arrangement,” said Brian Farley, Entellus President and CEO.
About Entellus Medical
Entellus Medical provides minimally invasive therapeutic solutions to healthcare providers and their patients who suffer from sinusitis. Based in Maple Grove, Minn., Entellus Medical manufactures, markets, and distributes its products throughout the United States. For more information about Entellus Medical, FinESS Sinus Treatment and the XprESS Multi-Sinus Dilation Tool, visit www.entellusmedical.com or call 763-463-1595.